Medical device firm Hygieia recently secured $1.5 million in investment capital from Oakwood Medical Investors, a physician-managed venture fund in St. Louis, Missouri.
Hygieia has developed the Diabetes Insulin Guidance System (DIGS), a handheld device that helps insulin-takers effectively manage their diabetes. DIGS adjusts insulin dosage weekly, to help patients get better.
The investment comes on the heels of a study presented at the June American Diabetes Association conference, covering the successful completion of Hygieia’s NIH-backed prospective trial at the International Diabetes Center in Minneapolis.
Founded in 2008, Hygieia was housed in the Ann Arbor SPARK Central Business Incubator and received support from the SPARK Business Accelerator. Last year, Hygieia was named the best medical device company in the Accelerate Michigan Innovation Competition.